Lv21
158 积分 2024-03-25 加入
Tumor Necrosis Factor-Like Ligand 1A/Death Receptor 3 Signaling Regulates the Generation of Pathogenic T Helper 9 Cells in Experimental Crohn’s Disease
3小时前
待确认
TL1A: a novel alarmin in airway, intestinal, and autoimmune disorders
4小时前
已完结
Molecular polymer bottlebrushes in nanomedicine: therapeutic and diagnostic applications
8天前
已完结
Normalization of Tumor Vessels by Lenvatinib‐Based Metallo‐Nanodrugs Alleviates Hypoxia and Enhances Calreticulin‐Mediated Immune Responses in Orthotopic HCC and Organoids
1个月前
已完结
Development of a sensitive screening method for selecting monoclonal antibodies to be internalized by cells
2个月前
已完结
PROTAC delivery in tumor immunotherapy: Where are we and where are we going?
3个月前
已完结
Chemistries of bifunctional PROTAC degraders
4个月前
已完结
Protacs in cancer therapy: mechanisms, design, clinical trials, and future directions
4个月前
已完结
Bispecific Nanobody‐Aptamer Conjugates for Enhanced Cancer Therapy in Solid Tumors
4个月前
已完结
Nanobodies: from structure to applications in non-injectable and bispecific biotherapeutic development
4个月前
已完结
皖公网安备34019202002308
